Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after platinum-based therapy: LUX-Head & Neck 3 phase Ill trial.
- Authors
- Guo, Y[Guo, Ye]; Ahn, MJ[Ahn, Myung-Ju]; Chan, ATC[Chan, Anthony T. C.]; Wang, CH[Wang, Cheng-Hsu]; Kang, JH[Kang, Jin Hyoung]; Kim, SB[Kim, Sung-Bae]; Bello, MD[Bello, Maximino De Guzman]; Arora, RS[Arora, Rajendra Singh]; Zhang, QY[Zhang, Qingyuan]; He, XH[He, Xiaohui]; Li, P[Li, Ping]; Dechaphunkul, A[Dechaphunkul, Arunee]; Kumar, V[Kumar, Vijay]; Kamble, K[Kamble, Krishna]; Li, W[Li, Wei]; Kandil, A[Kandil, Alaa]; Cohen, EEW[Cohen, Ezra E. W.]; Geng, Y[Geng, Yuan]; Zografos, L[Zografos, Lef]; Tang, PZ[Tang, Ping Zhang]
- Issue Date
- 20-May-2019
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.37, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 37
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.